NeoGenomics, Inc. recently announced that its PanTracer LBx liquid biopsy test has received Medicare coverage under the MolDX ...
NeoGenomics' PanTracer™ LBx test has received coverage from the Centers for Medicare & Medicaid Services’ Molecular ...
Management reiterated confidence that the next step is the publication of a draft local coverage determination (LCD) for EsoGuard, following the CAC meeting. Aklog stated, "we are very confident that ...
There are many Medicare options to consider, so understanding how to navigate them is important. You can begin considering Medicare options before you turn 65, which is when you first become eligible.
This article examines major items that Original Medicare medical insurance doesn't cover.